Generation Bio Co. (GBIO) Misses Q4 EPS by 2c

Generation Bio Co. (NASDAQ: GBIO) reported Q4 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $4.18 million versus the consensus estimate of $2.92 million.

For earnings history and earnings-related data on Generation Bio Co. (GBIO) click here.

You May Also Be Interested In

• Uber Is Said To Be In Advanced Talks On Delivery Hero Takeover - Bloomberg
• Arrow Electronics earns Microsoft Azure Virtual Desktop specialization
• UBS Reiterates Buy Rating on Boot Barn (BOOT), Expects Q1 Earnings Beat